Learn More
Medchemexpress LLC DOTA-EB-TATE | 2151063-66-8 | 95.4% | 2329.63 | 5 MG

Supplier: Medchemexpress LLC HYP107415MG
This peptide drug conjugate (PDC) is composed of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB). It is designed to improve the pharmacokinetics of SSTR2 analogs and reduce PRRT toxicity, and can also be utilized for the synthesis and research of Radionuclide-Drug Conjugates (RDCs).
- Composed of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB)
- Improves pharmacokinetics of SSTR2 analogs
- Reduces PRRT toxicity
- Utilized for the synthesis and research of Radionuclide-Drug Conjugates (RDCs)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.